HIV-2 EU—Supporting Standardized HIV-2 Drug Resistance Interpretation: An Update

Charlotte Charpentier; Dirk Berzow; Quentin Le Hingrat; Rolf Kaiser; Perpetua Gomes; Ana Claudia Miranda; Florence Damond; Jade Ghosn; Jeroen J.A. Van Kampen; Björn Erik Ole Jensen; Michael Böhm; Annemarie M.J. Wensing; Diane Descamps; Martin Obermeier

doi:10.1093/cid/ciaf110

HIV-2 EU—Supporting Standardized HIV-2 Drug Resistance Interpretation: An Update

Charlotte Charpentier
, Dirk Berzow
, Quentin Le Hingrat
, Rolf Kaiser
, Perpetua Gomes
, Ana Claudia Miranda
, Florence Damond
, Jade Ghosn
, Jeroen J.A. Van Kampen
, Björn Erik Ole Jensen
, Michael Böhm
, Annemarie M.J. Wensing
, Diane Descamps
, Martin Obermeier

Resultado de pesquisa: ???type-name??? › ???researchoutput.researchoutputtypes.contributiontojournal.article??? › revisão de pares

1 Citação (Scopus)

Resumo

Human immunodeficiency virus type 2 (HIV-2) is an attenuated retroviral infection characterized by specific natural susceptibility to antiretroviral drugs and acquired resistance profiles. Based on the latest knowledge of phenotypic data and clinical follow-up, HIV-2 resistance interpretation rules have been updated and implemented in a freely available resistance analysis tool.

Idioma original	???core.languages.en_GB???
Páginas (de-até)	539-542
Número de páginas	4
Revista	Clinical Infectious Diseases
Volume	81
Número de emissão	3
DOIs	https://doi.org/10.1093/cid/ciaf110
Estado da publicação	???researchoutput.status.published??? - 15 set. 2025

ODS da ONU

Este resultado contribui para o(s) seguinte(s) Objetivo(s) de Desenvolvimento Sustentável

ODS 3 Boa saúde e bem-estar

Acesso ao documento

10.1093/cid/ciaf110

Outros arquivos e links

Link to publication in Scopus

Citar isto

Charpentier, C., Berzow, D., Le Hingrat, Q., Kaiser, R., Gomes, P., Miranda, A. C., Damond, F., Ghosn, J., Van Kampen, J. J. A., Jensen, B. E. O., Böhm, M., Wensing, A. M. J., Descamps, D., & Obermeier, M. (2025). HIV-2 EU—Supporting Standardized HIV-2 Drug Resistance Interpretation: An Update. Clinical Infectious Diseases, 81(3), 539-542. https://doi.org/10.1093/cid/ciaf110

@article{c3881b238a5742ce8fee035136d7e923,

title = "HIV-2 EU—Supporting Standardized HIV-2 Drug Resistance Interpretation: An Update",

abstract = "Human immunodeficiency virus type 2 (HIV-2) is an attenuated retroviral infection characterized by specific natural susceptibility to antiretroviral drugs and acquired resistance profiles. Based on the latest knowledge of phenotypic data and clinical follow-up, HIV-2 resistance interpretation rules have been updated and implemented in a freely available resistance analysis tool.",

keywords = "HIV-2, Internet tool, drug-resistance rules, update, HIV-2/drug effects, European Union, Humans, Microbial Sensitivity Tests/standards, Drug Resistance, Viral, HIV Infections/virology, Anti-HIV Agents/pharmacology",

author = "Charlotte Charpentier and Dirk Berzow and \{Le Hingrat\}, Quentin and Rolf Kaiser and Perpetua Gomes and Miranda, \{Ana Claudia\} and Florence Damond and Jade Ghosn and \{Van Kampen\}, \{Jeroen J.A.\} and Jensen, \{Bj{\"o}rn Erik Ole\} and Michael B{\"o}hm and Wensing, \{Annemarie M.J.\} and Diane Descamps and Martin Obermeier",

year = "2025",

month = sep,

day = "15",

doi = "10.1093/cid/ciaf110",

language = "English",

volume = "81",

pages = "539--542",

journal = "Clinical Infectious Diseases",

issn = "1058-4838",

publisher = "Oxford University Press",

number = "3",

}

TY - JOUR

T1 - HIV-2 EU—Supporting Standardized HIV-2 Drug Resistance Interpretation

T2 - An Update

AU - Charpentier, Charlotte

AU - Berzow, Dirk

AU - Le Hingrat, Quentin

AU - Kaiser, Rolf

AU - Gomes, Perpetua

AU - Miranda, Ana Claudia

AU - Damond, Florence

AU - Ghosn, Jade

AU - Van Kampen, Jeroen J.A.

AU - Jensen, Björn Erik Ole

AU - Böhm, Michael

AU - Wensing, Annemarie M.J.

AU - Descamps, Diane

AU - Obermeier, Martin

PY - 2025/9/15

Y1 - 2025/9/15

N2 - Human immunodeficiency virus type 2 (HIV-2) is an attenuated retroviral infection characterized by specific natural susceptibility to antiretroviral drugs and acquired resistance profiles. Based on the latest knowledge of phenotypic data and clinical follow-up, HIV-2 resistance interpretation rules have been updated and implemented in a freely available resistance analysis tool.

AB - Human immunodeficiency virus type 2 (HIV-2) is an attenuated retroviral infection characterized by specific natural susceptibility to antiretroviral drugs and acquired resistance profiles. Based on the latest knowledge of phenotypic data and clinical follow-up, HIV-2 resistance interpretation rules have been updated and implemented in a freely available resistance analysis tool.

KW - HIV-2

KW - Internet tool

KW - drug-resistance rules

KW - update

KW - HIV-2/drug effects

KW - European Union

KW - Humans

KW - Microbial Sensitivity Tests/standards

KW - Drug Resistance, Viral

KW - HIV Infections/virology

KW - Anti-HIV Agents/pharmacology

UR - https://www.scopus.com/pages/publications/105017914519

U2 - 10.1093/cid/ciaf110

DO - 10.1093/cid/ciaf110

M3 - Article

C2 - 40071658

AN - SCOPUS:105017914519

SN - 1058-4838

VL - 81

SP - 539

EP - 542

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

IS - 3

ER -

HIV-2 EU—Supporting Standardized HIV-2 Drug Resistance Interpretation: An Update

Resumo

ODS da ONU

Acesso ao documento

Outros arquivos e links

Impressão digital

Citar isto